{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:34Z","timestamp":1761101014680},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T00:00:00Z","timestamp":1274659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T00:00:00Z","timestamp":1274659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/bmt.2010.114","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T13:10:40Z","timestamp":1274706640000},"page":"192-199","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY"],"prefix":"10.1038","volume":"46","author":[{"given":"S","family":"Naik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Laport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Lowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Miklos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Shizuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Blume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,24]]},"reference":[{"key":"BFbmt2010114_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bbmt.2003.08.004","volume":"9","author":"HC Fung","year":"2003","unstructured":"Fung HC, Stein A, Slovak M, O\u2019Donnell MR, Snyder DS, Cohen S et al. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant 2003; 9: 766\u2013771.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood.V61.5.949.949","volume":"61","author":"FR Appelbaum","year":"1983","unstructured":"Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM et al. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 1983; 61: 949\u2013953.","journal-title":"Blood"},{"key":"BFbmt2010114_CR3","first-page":"13","volume":"10","author":"RP Gale","year":"1996","unstructured":"Gale RP, Horowitz MM, Rees JK, Gray RG, Oken MM, Estey EH et al. Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 1996; 10: 13\u201319.","journal-title":"Leukemia"},{"key":"BFbmt2010114_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/sj.bmt.1704938","volume":"35","author":"P Kebriaei","year":"2005","unstructured":"Kebriaei P, Kline J, Stock W, Kasza K, Le Beau MM, Larson RA et al. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes. Bone Marrow Transplant 2005; 35: 965\u2013970.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010114_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbmt.2004.10.008","volume":"11","author":"R Wong","year":"2005","unstructured":"Wong R, Shahjahan M, Wang X, Thall PF, De Lima M, Khouri I et al. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant 2005; 11: 108\u2013114.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bmt.1704518","volume":"34","author":"M Yanada","year":"2004","unstructured":"Yanada M, Emi N, Naoe T, Sakamaki H, Iseki T, Hirabayashi N et al. Allogeneic myeloablative transplantation for patients aged 50 years and over. Bone Marrow Transplant 2004; 34: 29\u201335.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010114_CR7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","volume":"81","author":"KG Blume","year":"1993","unstructured":"Blume KG, Kopecky KJ, Henslee-Downey JP, Forman SJ, Stiff PJ, LeMaistre CF et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood 1993; 81: 2187\u20132193.","journal-title":"Blood"},{"issue":"12 Part 2","key":"BFbmt2010114_CR8","first-page":"2671","volume":"3","author":"AR Zander","year":"1997","unstructured":"Zander AR, Berger C, Kroger N, Stockshlader M, Kruger W, Horstmann M et al. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Clin Cancer Res 1997; 3 (12 Part 2): 2671\u20132675.","journal-title":"Clin Cancer Res"},{"key":"BFbmt2010114_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.bmt.1702598","volume":"26","author":"N Kroger","year":"2000","unstructured":"Kroger N, Zabelina T, Sonnenberg S, Kruger W, Renges H, Stute N et al. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Bone Marrow Transplant 2000; 26: 711\u2013716.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010114_CR10","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075\u20134083.","journal-title":"Blood"},{"key":"BFbmt2010114_CR11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079\u20132088.","journal-title":"Blood"},{"key":"BFbmt2010114_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V36.4.507.507","volume":"36","author":"ED Thomas","year":"1970","unstructured":"Thomas ED, Storb R . Technique for human marrow grafting. Blood 1970; 36: 507\u2013515.","journal-title":"Blood"},{"key":"BFbmt2010114_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbmt.2006.02.009","volume":"12","author":"LY Law","year":"2006","unstructured":"Law LY, Horning SJ, Wong RM, Johnston LJ, Laport GG, Lowsky R et al. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2006; 12: 703\u2013711.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbmt.2003.10.007","volume":"10","author":"GA Fraser","year":"2004","unstructured":"Fraser GA, Walker II . Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control\/Infectious Diseases Society of America\/American Society for Blood and Marrow Transplantation guideline recommendations. Biol Blood Marrow Transplant 2004; 10: 287\u2013297.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR15","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562\u20131568.","journal-title":"J Clin Oncol"},{"key":"BFbmt2010114_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2010114_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt2010114_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267\u2013276.","journal-title":"Blood"},{"key":"BFbmt2010114_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","volume":"114","author":"AC Vigorito","year":"2009","unstructured":"Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009; 114: 702\u2013708.","journal-title":"Blood"},{"key":"BFbmt2010114_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bmt.1704533","volume":"34","author":"SK Sohn","year":"2004","unstructured":"Sohn SK, Kim DH, Kim JG, Lee NY, Suh JS, Lee KS et al. Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onset. Bone Marrow Transplant 2004; 34: 63\u201368.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010114_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR22","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.1200\/JCO.2005.02.0057","volume":"23","author":"S Tauro","year":"2005","unstructured":"Tauro S, Craddock C, Peggs K, Begum G, Mahendra P, Cook G et al. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. J Clin Oncol 2005; 23: 9387\u20139393.","journal-title":"J Clin Oncol"},{"key":"BFbmt2010114_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/sj.leu.2403482","volume":"18","author":"WR Drobyski","year":"2004","unstructured":"Drobyski WR . The role of allogeneic transplantation in high-risk acute myelogenous leukemia. Leukemia 2004; 18: 1565\u20131568.","journal-title":"Leukemia"},{"key":"BFbmt2010114_CR24","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","volume":"98","author":"G Socie","year":"2001","unstructured":"Socie G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569\u20133574.","journal-title":"Blood"},{"key":"BFbmt2010114_CR25","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbmt.2007.03.003","volume":"13","author":"JA Russell","year":"2007","unstructured":"Russell JA, Savoie ML, Balogh A, Turner AR, Larratt L, Chaudhry MA et al. Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400\u2009cGy total-body irradiation, and thymoglobulin. Biol Blood Marrow Transplant 2007; 13: 814\u2013821.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR26","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1080\/10428190701671051","volume":"48","author":"A Shimoni","year":"2007","unstructured":"Shimoni A, Hardan I, Shem-Tov N, Rand A, Yerushalmi R, Nagler A . Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes. Leuk Lymphoma 2007; 48: 2352\u20132359.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2010114_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.bmt.1704867","volume":"35","author":"SS Farag","year":"2005","unstructured":"Farag SS, Bolwell BJ, Elder PJ, Kalaycio M, Lin T, Pohlman B et al. High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia. Bone Marrow Transplant 2005; 35: 653\u2013661.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2010114_CR28","first-page":"S25","volume":"12","author":"FR Appelbaum","year":"1998","unstructured":"Appelbaum FR, Anderson J . Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. Leukemia 1998; 12 (Suppl 1): S25\u2013S29.","journal-title":"Leukemia"},{"key":"BFbmt2010114_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbmt.2007.07.016","volume":"14","author":"P Armand","year":"2008","unstructured":"Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Ritz J et al. A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 28\u201335.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010114_CR30","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","volume":"19","author":"C Cutler","year":"2001","unstructured":"Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685\u20133691.","journal-title":"J Clin Oncol"},{"key":"BFbmt2010114_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1600-0609.2004.00249.x","volume":"72","author":"SK Sohn","year":"2004","unstructured":"Sohn SK, Kim DH, Kim JG, Sung WJ, Baek JH, Lee NY et al. Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases. Eur J Haematol 2004; 72: 430\u2013436.","journal-title":"Eur J Haematol"},{"key":"BFbmt2010114_CR32","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1182\/blood.V99.12.4370","volume":"99","author":"P Guardiola","year":"2002","unstructured":"Guardiola P, Runde V, Bacigalupo A, Ruutu T, Locatelli F, Boogaerts MA et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 2002; 99: 4370\u20134378.","journal-title":"Blood"},{"key":"BFbmt2010114_CR33","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1704246","volume":"32","author":"MC del Canizo","year":"2003","unstructured":"del Canizo MC, Martinez C, Conde E, Vallejo C, Brunet S, Sanz G et al. Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry. Bone Marrow Transplant 2003; 32: 987\u2013992.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010114_CR34","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood.V85.5.1391.bloodjournal8551391","volume":"85","author":"RA Brown","year":"1995","unstructured":"Brown RA, Wolff SN, Fay JW, Pineiro L, Collins Jr RH, Lynch JP et al. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. Blood 1995; 85: 1391\u20131395.","journal-title":"Blood"},{"key":"BFbmt2010114_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.bmt.1705879","volume":"41","author":"R Martino","year":"2008","unstructured":"Martino R, Valcarcel D, Brunet S, Sureda A, Sierra J . Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. Bone Marrow Transplant 2008; 41: 33\u201338.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010114_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood-2006-10-043299","volume":"110","author":"MS Tallman","year":"2007","unstructured":"Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM et al. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood 2007; 110: 409\u2013417.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2010114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:18:46Z","timestamp":1648037926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2010114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,24]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFbmt2010114"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.114","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,24]]},"assertion":[{"value":"14 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}